1. Home
  2. PHAR vs WLDN Comparison

PHAR vs WLDN Comparison

Compare PHAR & WLDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAR
  • WLDN
  • Stock Information
  • Founded
  • PHAR 1988
  • WLDN 1964
  • Country
  • PHAR Netherlands
  • WLDN United States
  • Employees
  • PHAR N/A
  • WLDN N/A
  • Industry
  • PHAR Biotechnology: Pharmaceutical Preparations
  • WLDN Military/Government/Technical
  • Sector
  • PHAR Health Care
  • WLDN Consumer Discretionary
  • Exchange
  • PHAR Nasdaq
  • WLDN Nasdaq
  • Market Cap
  • PHAR 627.5M
  • WLDN 581.0M
  • IPO Year
  • PHAR N/A
  • WLDN 2006
  • Fundamental
  • Price
  • PHAR $9.98
  • WLDN $38.09
  • Analyst Decision
  • PHAR Strong Buy
  • WLDN Strong Buy
  • Analyst Count
  • PHAR 3
  • WLDN 3
  • Target Price
  • PHAR $27.00
  • WLDN $44.33
  • AVG Volume (30 Days)
  • PHAR 6.0K
  • WLDN 121.3K
  • Earning Date
  • PHAR 03-13-2025
  • WLDN 03-06-2025
  • Dividend Yield
  • PHAR N/A
  • WLDN N/A
  • EPS Growth
  • PHAR N/A
  • WLDN 802.09
  • EPS
  • PHAR N/A
  • WLDN 1.63
  • Revenue
  • PHAR $285,745,000.00
  • WLDN $577,414,000.00
  • Revenue This Year
  • PHAR $20.08
  • WLDN N/A
  • Revenue Next Year
  • PHAR $9.22
  • WLDN $7.28
  • P/E Ratio
  • PHAR N/A
  • WLDN $23.37
  • Revenue Growth
  • PHAR 30.64
  • WLDN 23.47
  • 52 Week Low
  • PHAR $6.65
  • WLDN $18.37
  • 52 Week High
  • PHAR $13.20
  • WLDN $50.00
  • Technical
  • Relative Strength Index (RSI)
  • PHAR 56.13
  • WLDN 45.58
  • Support Level
  • PHAR $9.37
  • WLDN $34.73
  • Resistance Level
  • PHAR $10.15
  • WLDN $39.09
  • Average True Range (ATR)
  • PHAR 0.50
  • WLDN 1.18
  • MACD
  • PHAR -0.09
  • WLDN 0.21
  • Stochastic Oscillator
  • PHAR 57.53
  • WLDN 76.36

About PHAR Pharming Group N.V.

Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.

About WLDN Willdan Group Inc.

Willdan Group Inc is a provider of professional technical and consulting services to utilities, private industry, and public agencies at all levels of government. It operates in the business segments of Energy and Engineering and Consulting. It generates the majority of its revenue from the Energy segment, which includes services such as audit and surveys, program design, master planning, benchmarking analysis, design engineering, construction management, performance contracting, installation, advances in software and data analytics, and other services. All of its revenue is derived from the domestic markets.

Share on Social Networks: